Brief: Athira Pharma Q3 EPS USD -0.87

LeonaBio

09/11/2023 21:05

Nov 09 (Reuters) - Athira Pharma Q3 operating expenses USD 35.042 million.
* Q3 operating income USD -35.042 million
* Q3 net income USD -32.97 million